---

phase trial (subgroup of trial) → ReceivesAction → conducted	0.77
controlled trial (subgroup of trial) → ReceivesAction → identified	0.73
trial → HasProperty → open	0.71
trial → ReceivesAction → completed	0.70
trial → ReceivesAction → registered	0.70
trial → ReceivesAction → conducted	0.69
jury trial (subgroup of trial) → HasPrerequisite → extensive paperwork	0.69
trial → CapableOf → enrol patient	0.68
bench trial (subgroup of trial) → IsA → trial	0.68
jury trial (subgroup of trial) → ReceivesAction → required	0.68
trial → ReceivesAction → conducted in accordance	0.68
trial → CapableOf → evaluate efficacy	0.67
phase trial (subgroup of trial) → HasProperty → underway	0.66
trial → ReceivesAction → conducted in the united states	0.66
trial → ReceivesAction → concluded	0.66
trial → HasProperty → ongoing	0.65
trial → ReceivesAction → randomized	0.65
trial → ReceivesAction → excluded	0.65
trial → CapableOf → begin	0.65
phase trial (subgroup of trial) → CapableOf → evaluate efficacy	0.65
trial → ReceivesAction → designed	0.65
trial → HasProperty → small	0.64
trial → ReceivesAction → included in the analysis	0.64
trial → ReceivesAction → included in the meta-analysis	0.64
trial → ReceivesAction → held in the state	0.64
trial → ReceivesAction → run	0.63
trial → HasProperty → relevant	0.63
phase trial (subgroup of trial) → ReceivesAction → completed	0.63
trial → ReceivesAction → registered at clinicaltrials.gov	0.63
trial → HasProperty → unique	0.63
trial → HasProperty → underway	0.62
trial → CapableOf → start with a fixation cross	0.61
trial → HasProperty → successful	0.61
trial → HasProperty → valid	0.61
trial → ReceivesAction → designed to assess tolerability	0.61
trial → ReceivesAction → conducted in australia	0.61
trial → ReceivesAction → repeated	0.61
trial → CapableOf → show significant reduction	0.61
trial → HasSubevent → verdict	0.61
trial → ReceivesAction → recorded	0.61
trial → ReceivesAction → presented in random order	0.61
trial → HasProperty → important	0.60
trial → ReceivesAction → analyzed	0.60
trial → ReceivesAction → conducted in compliance	0.60
trial → HasProperty → public	0.60
trial → ReceivesAction → selected	0.59
fair trial (subgroup of trial) → HasProperty → impossible	0.59
jury trial (subgroup of trial) → HasProperty → more complex than nonjury trials	0.59
trial → HasProperty → free	0.59
trial → HasA → limitation	0.59
trial → ReceivesAction → stopped	0.59
trial → ReceivesAction → initiated	0.59
trial → ReceivesAction → heard by judge	0.58
trial → ReceivesAction → conducted in europe	0.58
trial → HasProperty → smaller	0.57
trial → ReceivesAction → concerned	0.57
trial → ReceivesAction → funded by grant	0.57
trial → HasProperty → blind	0.57
trial → CapableOf → enrol participant	0.57
trial → ReceivesAction → combined	0.57
jury trial (subgroup of trial) → ReceivesAction → waived	0.57
phase trial (subgroup of trial) → HasProperty → ongoing	0.57
trial → CapableOf → meet criterion	0.57
trial → HasProperty → independent	0.57
trial → ReceivesAction → carried out in accordance	0.57
trial → HasProperty → identical	0.57
trial → ReceivesAction → conducted in the uk	0.57
trial → ReceivesAction → conducted in china	0.56
criminal trial (subgroup of trial) → HasProperty → fair	0.56
trial → CapableOf → test our faith	0.56
trial → HasProperty → heterogeneous	0.56
trial → HasProperty → placebo-controlled	0.56
trial → HasProperty → short	0.56
trial → ReceivesAction → shown	0.56
trial → ReceivesAction → approved by institutional review boards	0.56
trial → HasProperty → unfair	0.56
trial → CapableOf → evaluate intervention	0.56
trial → ReceivesAction → conducted in india	0.56
trial → HasProperty → political	0.56
trial → ReceivesAction → listed in table	0.56
trial → HasProperty → unknown	0.56
trial → ReceivesAction → conducted in italy	0.56
trial → HasProperty → positive	0.56
trial → ReceivesAction → assessed for quality	0.56
trial → CapableOf → show increase	0.56
trial → AtLocation → high risk of bias	0.56
trial → ReceivesAction → published in english	0.55
trial → ReceivesAction → scheduled for november	0.55
trial → CapableOf → involve the participation of human subjects	0.55
trial → ReceivesAction → approved by the ethics committee	0.55
trial → ReceivesAction → pooled	0.55
trial → ReceivesAction → implemented	0.55
trial → ReceivesAction → funded by industry	0.55
trial → ReceivesAction → of high quality	0.55
trial → ReceivesAction → conducted in asia	0.55
trial → ReceivesAction → held without jury	0.55
trial → HasProperty → expensive	0.55
trial → CapableOf → report result	0.55
trial → CapableOf → investigate safety	0.55
trial → HasProperty → larger	0.55
trial → ReceivesAction → conducted in 2013	0.55
trial → CapableOf → involve people	0.54
trial → CapableOf → run for six months	0.54
trial → CapableOf → provide datum	0.54
trial → CapableOf → follow controlled protocol	0.54
trial → ReceivesAction → funded by pfizer	0.54
party → HasA → trial	0.54
trial → ReceivesAction → suspended	0.54
trial → CapableOf → report reduction	0.54
trial → ReceivesAction → eligible for inclusion	0.54
trial → ReceivesAction → conducted in germany	0.54
trial → CapableOf → last three weeks	0.54
new trial (subgroup of trial) → ReceivesAction → based on discovered evidence	0.54
trial → ReceivesAction → postponed	0.54
trial → CapableOf → look at drug	0.53
trial → CapableOf → report mortality	0.53
trial → ReceivesAction → sponsored by pharmaceutical companies	0.53
trial → CapableOf → take place in the united states	0.53
trial → ReceivesAction → funded by pharmaceutical companies	0.53
trial → CapableOf → investigate patient	0.53
trial → HasA → unclear risk of bias	0.53
trial → HasProperty → common	0.53
trial → CapableOf → take place in the uk	0.53
trial → ReceivesAction → adjourned	0.53
trial → CapableOf → start with a fixation point	0.53
trial → CapableOf → meet eligibility criteria	0.53
trial → CapableOf → compare reboxetine	0.53
trial → HasProperty → proper	0.53
trial → CapableOf → show trend	0.53
trial → ReceivesAction → conducted in canada	0.53
trial → CapableOf → raise question	0.52
trial → CapableOf → evaluate tolerability	0.52
trial → ReceivesAction → cancelled	0.52
trial → HasProperty → suitable	0.52
trial → ReceivesAction → removed	0.52
trial → ReceivesAction → due to start	0.52
trial → CapableOf → show similar results	0.52
trial → CapableOf → originate in china	0.52
trial → ReceivesAction → ordered	0.52
trial → HasProperty → double-blind	0.52
trial → CapableOf → provide opportunity	0.52
trial → ReceivesAction → delayed	0.52
trial → HasProperty → necessary	0.52
trial → ReceivesAction → held behind closed doors	0.52
trial → CapableOf → involve child	0.52
trial → ReceivesAction → held in public	0.52
trial → ReceivesAction → presented in randomized order	0.52
trial → ReceivesAction → resolved	0.52
drug → AtLocation → trial	0.52
trial → ReceivesAction → conducted in patient	0.52
trial → CapableOf → report datum	0.52
trial → HasA → purpose	0.52
trial → CapableOf → take 2-3 days	0.52
trial → CapableOf → pave the way	0.52
new trial (subgroup of trial) → ReceivesAction → granted	0.52
trial → ReceivesAction → reported	0.51
trial → CapableOf → show significant improvement	0.51
trial → HasA → small sample sizes	0.51
trial → CapableOf → start in 2006	0.51
trial → CapableOf → receive support	0.51
trial → HasA → mixed results	0.51
trial → ReceivesAction → replicated	0.51
trial → CapableOf → originate in japan	0.51
trial → CapableOf → originate in hong kong	0.51
trial → CapableOf → produce evidence	0.51
trial → HasProperty → classified	0.51
trial → HasProperty → good	0.51
trial → ReceivesAction → heard	0.51
trial → ReceivesAction → conducted in north america	0.51
trial → ReceivesAction → heard by jury	0.51
trial → ReceivesAction → put on hold	0.51
new trial (subgroup of trial) → ReceivesAction → granted by the court	0.51
trial → HasProperty → few	0.51
marriage → HasA → trial	0.51
trial → HasProperty → prospective	0.51
trial → ReceivesAction → held in open court	0.51
trial → ReceivesAction → regarded	0.51
trial → ReceivesAction → completed in december	0.51
trial → CapableOf → target patient	0.51
trial → CapableOf → recruit patient	0.51
trial → ReceivesAction → carried out in the usa	0.51
trial → ReceivesAction → continued	0.50
new trial (subgroup of trial) → ReceivesAction → warranted	0.50
trial → CapableOf → meet the inclusion criteria	0.50
controlled trial (subgroup of trial) → ReceivesAction → required	0.50
trial → ReceivesAction → discarded	0.50
phase trial (subgroup of trial) → HasProperty → successful	0.50
trial → ReceivesAction → extended	0.50
trial → CapableOf → take month	0.50
trial → HasProperty → complex	0.50
trial → CapableOf → test new treatments	0.50
trial → HasProperty → unblinded	0.50
trial → ReceivesAction → accepted	0.50
trial → ReceivesAction → timed	0.50
trial → ReceivesAction → included in the cochrane review	0.50
trial → ReceivesAction → arranged	0.50
trial → ReceivesAction → laid out in randomized complete block design	0.50
trial → CapableOf → begin in june	0.50
trial → HasProperty → difficult	0.50
trial → CapableOf → examine the effect	0.50
trial → CapableOf → begin in september	0.50
trial → ReceivesAction → sponsored by company	0.50
trial → ReceivesAction → published in 2015	0.50
trial → CapableOf → treat patient	0.50
trial → CapableOf → show benefit	0.50
trial → CapableOf → begin on march	0.50
trial → ReceivesAction → limited	0.50
trial → ReceivesAction → biased	0.49
trial → HasProperty → voluntary	0.49
trial → ReceivesAction → judged to be at low risk of bias	0.49
trial → ReceivesAction → inspected	0.49
trial → ReceivesAction → reported in accordance	0.49
trial → ReceivesAction → carried out in europe	0.49
trial → HasProperty → appropriate	0.49
trial → HasProperty → negative	0.49
trial → CapableOf → recruit participant	0.49
trial → CapableOf → last two weeks	0.49
trial → CapableOf → begin in october	0.49
trial → ReceivesAction → rescheduled	0.49
trial → HasProperty → fair	0.49
phase trial (subgroup of trial) → CapableOf → assess tolerability	0.49
trial → ReceivesAction → planned	0.49
trial → ReceivesAction → held	0.49
trial → CapableOf → involve hundreds of patients	0.49
trial → ReceivesAction → conducted in japan	0.49
case → HasPrerequisite → trial	0.49
trial → ReceivesAction → set	0.49
trial → HasProperty → emotional	0.49
trial → HasProperty → rigorous	0.49
trial → ReceivesAction → published in jama	0.49
trial → CapableOf → begin in january	0.49
trial → CapableOf → satisfy normal requirements	0.49
trial → ReceivesAction → presented in pseudorandom order	0.49
trial → HasA → three arms	0.49
trial → ReceivesAction → sown	0.49
trial → CapableOf → get closer	0.49
trial → ReceivesAction → conducted in adult	0.49
trial → ReceivesAction → regulated	0.49
trial → CapableOf → begin in november	0.49
trial → ReceivesAction → published in journal	0.49
jury trial (subgroup of trial) → ReceivesAction → held	0.49
trial → CapableOf → provide information	0.49
trial → ReceivesAction → conducted in child	0.48
trial → ReceivesAction → held in miami	0.48
trial → CapableOf → last for year	0.48
trial → CapableOf → show reduction	0.48
trial → CapableOf → enroll small number of patients	0.48
trial → CapableOf → begin on february	0.48
trial → CapableOf → begin in may	0.48
trial → ReceivesAction → televised	0.48
trial → CapableOf → begin with opening statements	0.48
trial → HasA → jury	0.48
trial → HasProperty → evident	0.48
trial → HasProperty → final	0.48
trial → PartOf → life	0.48
trial → HasProperty → exceptional	0.48
trial → HasProperty → brief	0.48
trial → CapableOf → begin in april	0.48
trial → CapableOf → begin on monday	0.48
trial → CapableOf → evaluate pharmacokinetic	0.48
trial → CapableOf → show positive results	0.48
trial → CapableOf → end in mistrial	0.48
trial → CapableOf → last for month	0.47
trial → ReceivesAction → published in 2004	0.47
trial → ReceivesAction → closed	0.47
trial → ReceivesAction → designed to evaluate safety	0.47
trial → ReceivesAction → terminated	0.47
trial → HasA → datum	0.47
trial → CapableOf → take place in europe	0.47
trial → CapableOf → find significant difference	0.47
trial → CapableOf → begin in july	0.47
trial → CapableOf → provide important information	0.47
trial → CapableOf → report significant results	0.47
trial → ReceivesAction → filmed	0.47
trial → CapableOf → take place in india	0.47
trial → CapableOf → look at five major classes of drug	0.47
trial → ReceivesAction → flawed	0.47
trial → CapableOf → take year	0.47
trial → ReceivesAction → held in the united states	0.47
trial → HasProperty → double-blinded	0.47
trial → ReceivesAction → included in systematic review	0.47
trial → CapableOf → remain unpublished	0.47
trial → ReceivesAction → conducted in partnership	0.47
trial → CapableOf → provide evidence	0.47
trial → HasA → low risk of bias	0.47
trial → CapableOf → last several days	0.47
new trial (subgroup of trial) → ReceivesAction → required	0.47
trial → HasProperty → long	0.47
trial → ReceivesAction → abandoned	0.46
trial → CapableOf → begin in december	0.46
trial → CapableOf → test vaccine	0.46
trial → HasProperty → risky	0.46
trial → HasA → stimulus	0.46
trial → CapableOf → take place in chile	0.46
trial → ReceivesAction → conducted in country	0.46
trial → ReceivesAction → completed in march	0.46
trial → ReceivesAction → identified	0.46
trial → ReceivesAction → conducted in collaboration	0.46
trial → ReceivesAction → tried	0.46
trial → CapableOf → begin on august	0.46
jury trial (subgroup of trial) → HasProperty → more extensive	0.46
trial → ReceivesAction → collected	0.46
trial → CapableOf → shed light	0.46
trial → AtLocation → such place	0.46
trial → ReceivesAction → conducted in hospital	0.46
trial → ReceivesAction → conducted in high-income countries	0.46
trial → CapableOf → come into our lives	0.46
trial → CapableOf → focus on patient	0.46
trial → CapableOf → evaluate the safety	0.46
trial → ReceivesAction → rejected	0.46
trial → ReceivesAction → conducted in argentina	0.45
trial → CapableOf → use surrogate endpoints	0.45
trial → ReceivesAction → published in the bmj	0.45
trial → ReceivesAction → closed to the public	0.45
trial → HasProperty → beneficial	0.45
new trial (subgroup of trial) → ReceivesAction → ordered	0.45
phase trial (subgroup of trial) → ReceivesAction → randomised	0.45
trial → CapableOf → last two to three weeks	0.45
trial → ReceivesAction → designed to assess efficacy	0.45
trial → ReceivesAction → set for june	0.45
trial → CapableOf → strengthen our faith	0.45
trial → CapableOf → collect datum	0.45
trial → ReceivesAction → of low quality	0.45
trial → HasProperty → right	0.45
trial → ReceivesAction → conducted on treatment	0.45
trial → CapableOf → get under way	0.45
trial → CapableOf → compare new treatment	0.45
trial → ReceivesAction → conducted on human	0.45
trial → CapableOf → cost money	0.45
trial → ReceivesAction → sponsored by the national cancer institute	0.45
trial → HasProperty → intense	0.45
trial → ReceivesAction → sponsored by nih	0.45
trial → ReceivesAction → related	0.45
trial → ReceivesAction → targeted	0.45
trial → ReceivesAction → conducted on people	0.45
trial → ReceivesAction → averaged	0.45
trial → ReceivesAction → offered by the business	0.44
trial → HasSubevent → acquittal	0.44
trial → HasProperty → low	0.44
trial → ReceivesAction → scheduled for september	0.44
trial → HasProperty → large	0.44
trial → CapableOf → consist of two phases	0.44
trial → HasProperty → possible	0.44
trial → ReceivesAction → held in april	0.44
trial → ReceivesAction → designed to evaluate pharmacokinetic	0.44
trial → ReceivesAction → scheduled	0.44
trial → CapableOf → take week	0.44
trial → HasProperty → local	0.44
trial → ReceivesAction → held in march	0.44
trial → ReceivesAction → funded by the national institutes of health	0.44
trial → ReceivesAction → monitored	0.44
trial → HasProperty → self-paced	0.44
trial → HasProperty → accessible	0.44
trial → CapableOf → take day	0.43
trial → ReceivesAction → funded by the national institute	0.43
trial → HasProperty → temporary	0.43
trial → HasProperty → exempt	0.43
trial → ReceivesAction → set for february	0.43
trial → CapableOf → come our way	0.43
trial → ReceivesAction → established	0.43
trial → HasProperty → eligible	0.43
trial → ReceivesAction → had	0.43
trial → ReceivesAction → organized	0.43
trial → ReceivesAction → rigged	0.43
trial → CapableOf → end in december	0.43
trial → HasProperty → pending	0.43
trial → HasProperty → time-consuming	0.43
trial → HasProperty → active	0.43
trial → ReceivesAction → won	0.42
trial → ReceivesAction → conducted in france	0.42
trial → CapableOf → report negative results	0.42
trial → CapableOf → demonstrate the feasibility	0.42
trial → ReceivesAction → conducted at two prestigious cancer centers	0.42
trial → CapableOf → start in 2015	0.42
trial → ReceivesAction → completed by particular tribunal	0.42
jury trial (subgroup of trial) → ReceivesAction → heard before judge	0.42
phase trial (subgroup of trial) → CapableOf → assess pharmacokinetic	0.42
trial → HasProperty → rare	0.42
trial → CapableOf → assess pharmacodynamic	0.42
trial → ReceivesAction → registered with the chinese clinical trial registry	0.42
trial → ReceivesAction → scheduled for january	0.42
trial → ReceivesAction → allowed	0.42
trial → ReceivesAction → conducted in addition	0.42
trial → CapableOf → save time	0.42
trial → ReceivesAction → scheduled for may	0.42
trial → CapableOf → end in november	0.42
trial → ReceivesAction → resumed	0.42
trial → ReceivesAction → scheduled for october	0.42
trial → ReceivesAction → expected	0.42
trial → ReceivesAction → likely to published	0.42
trial → HasProperty → new	0.42
trial → ReceivesAction → about to begin	0.41
trial → CapableOf → end in hung jury	0.41
trial → HasProperty → light	0.41
trial → ReceivesAction → overcome	0.41
trial → HasProperty → imminent	0.41
trial → ReceivesAction → held in secret	0.41
trial → ReceivesAction → launched	0.41
trial → ReceivesAction → held in nuremberg	0.41
trial → ReceivesAction → funded by the medical research council	0.41
phase trial (subgroup of trial) → CapableOf → enrol patient	0.41
trial → HasProperty → easy	0.41
trial → ReceivesAction → recommended	0.41
trial → ReceivesAction → conducted in south africa	0.41
trial → CapableOf → provide insight	0.41
trial → CapableOf → test the hypothesis	0.41
trial → CapableOf → use biomarker	0.41
trial → ReceivesAction → followed	0.41
trial → ReceivesAction → understood	0.41
trial → HasProperty → single blind	0.41
trial → ReceivesAction → warranted	0.41
right (aspect of defendant) → HasA → trial	0.41
trial → CapableOf → show decrease	0.41
trial → CapableOf → begin with jury selection	0.41
trial → CapableOf → end in june	0.41
trial → HasProperty → more difficult	0.41
trial → HasProperty → disappointing	0.41
trial → HasProperty → more costly	0.41
trial → CapableOf → begin on tuesday	0.41
trial → ReceivesAction → scheduled for july	0.41
trial → ReceivesAction → carried out in germany	0.41
trial → ReceivesAction → separated	0.41
trial → CapableOf → resume on monday	0.41
trial → ReceivesAction → reported as abstract	0.40
trial → CapableOf → assess chelation therapy	0.40
trial → HasProperty → impartial	0.40
trial → HasSubevent → judgment	0.40
trial → HasProperty → exciting	0.40
trial → CapableOf → occur on other hand	0.40
trial → ReceivesAction → broadcast	0.40
trial → CapableOf → take several years	0.40
trial → CapableOf → test tolerability	0.40
trial → CapableOf → come to close	0.40
trial → HasProperty → void	0.40
trial → HasA → methodological flaws	0.40
trial → HasProperty → impressive	0.40
trial → CapableOf → show positive effect	0.40
trial → ReceivesAction → submitted to the fda	0.40
free trial (subgroup of trial) → CapableOf → send up to 100 emails	0.40
trial → HasProperty → observational	0.40
trial → CapableOf → end with verdict	0.40
trial → HasProperty → real	0.40
trial → HasSubevent → conviction	0.40
trial → HasProperty → the largest	0.40
trial → CapableOf → take time	0.40
trial → CapableOf → fail to show benefit	0.40
trial → CapableOf → take place in november	0.40
trial → CapableOf → answer question	0.40
trial → ReceivesAction → expanded	0.40
trial → CapableOf → look at the impact	0.40
trial → CapableOf → consist of two parts	0.40
trial → CapableOf → confirm result	0.39
trial → CapableOf → begin enrolling patient	0.39
trial → ReceivesAction → created	0.39
trial → ReceivesAction → judged to be at high risk of bias	0.39
trial → CapableOf → assess mortality	0.39
fair trial (subgroup of trial) → HasProperty → possible	0.39
trial → ReceivesAction → examined	0.39
trial → ReceivesAction → scheduled to begin in march	0.39
trial → ReceivesAction → held in january	0.39
trial → CapableOf → last two years	0.39
trial → ReceivesAction → funded by merck	0.39
trial → ReceivesAction → funded by cancer research uk	0.39
trial → CapableOf → begin in 2017	0.39
trial → CapableOf → begin in mid	0.39
trial → CapableOf → last six weeks	0.39
trial → CapableOf → study the side effects	0.39
trial → HasProperty → the most important	0.39
trial → CapableOf → begin on oct.	0.39
trial → ReceivesAction → developed	0.39
defendant → HasA → trial	0.39
trial → ReceivesAction → scheduled for december	0.38
trial → CapableOf → last several months	0.38
trial → CapableOf → confirm finding	0.38
trial → AtLocation → early stages	0.38
trial → ReceivesAction → due to finish	0.38
trial → HasProperty → inevitable	0.38
trial → ReceivesAction → changed	0.38
trial → HasProperty → imperfect	0.38
trial → HasProperty → tedious	0.38
trial → HasProperty → excellent	0.38
trial → HasProperty → overdue	0.38
trial → ReceivesAction → held in court	0.38
trial → ReceivesAction → conducted outside the u.s.	0.38
trial → ReceivesAction → announced	0.38
trial → ReceivesAction → published in the lancet	0.38
trial → ReceivesAction → pushed	0.38
trial → ReceivesAction → scheduled to begin on april	0.38
trial → CapableOf → enroll 12 patients	0.38
trial → AtLocation → advanced stage	0.38
trial → CapableOf → run for two years	0.38
trial → ReceivesAction → adjourned until may	0.38
trial → ReceivesAction → scheduled to start in february	0.38
trial → ReceivesAction → likely to be valid	0.38
trial → CapableOf → begin in 2009	0.38
trial → ReceivesAction → led by researcher	0.38
phase trial (subgroup of trial) → CapableOf → involve patient	0.38
trial → HasProperty → impossible	0.38
trial → CapableOf → end on march	0.38
trial → ReceivesAction → held in february	0.38
trial → ReceivesAction → adjourned until november	0.38
trial → ReceivesAction → due to end	0.38
trial → CapableOf → end on september	0.38
trial → ReceivesAction → held in july	0.38
trial → CapableOf → last four weeks	0.38
trial → ReceivesAction → conducted in 2014	0.38
trial → ReceivesAction → re	0.38
trial → CapableOf → begin in early 2016	0.38
phase trial (subgroup of trial) → CapableOf → recruit participant	0.38
trial → HasProperty → useless	0.38
trial → HasProperty → unsuccessful	0.37
trial → CapableOf → assess improvement	0.37
trial → CapableOf → take place in december	0.37
trial → CapableOf → end in conviction	0.37
trial → ReceivesAction → funded by blood institute	0.37
trial → ReceivesAction → postponed to march	0.37
trial → ReceivesAction → held in august	0.37
trial → HasProperty → the latest	0.37
trial → CapableOf → set precedent	0.37
trial → CapableOf → end in hung juries	0.37
trial → ReceivesAction → published in 2016	0.37
trial → ReceivesAction → conducted in the netherlands	0.37
trial → ReceivesAction → carried out in canada	0.37
trial → HasProperty → effective	0.37
trial → HasProperty → confusing	0.37
trial → ReceivesAction → aborted	0.37
trial → IsA → experiment	0.37
trial → ReceivesAction → held before the international military tribunal	0.37
trial → CapableOf → mark first time	0.37
trial → CapableOf → run through october	0.37
trial → CapableOf → end in october	0.37
trial → CapableOf → continue on monday	0.37
trial → ReceivesAction → funded by the national heart	0.37
trial → CapableOf → evaluate preliminary efficacy	0.37
trial → CapableOf → end in january	0.37
trial → CapableOf → lay the groundwork	0.37
trial → CapableOf → find significant effect	0.37
trial → CapableOf → last three months	0.37
trial → ReceivesAction → conducted in 2017	0.37
trial → HasProperty → interpretable	0.37
trial → CapableOf → end in february	0.37
trial → ReceivesAction → funded by astrazeneca	0.37
trial → CapableOf → gain experience	0.37
trial → HasProperty → inadequate	0.37
controlled trial (subgroup of trial) → CapableOf → demonstrate efficacy	0.37
trial → ReceivesAction → convicted	0.37
trial → ReceivesAction → listed on clinicaltrials.gov	0.36
trial → ReceivesAction → published in 2012	0.36
trial → ReceivesAction → held before u.s. military courts	0.36
trial → ReceivesAction → approved by the fda	0.36
trial → CapableOf → accrue patient	0.36
trial → CapableOf → end in april	0.36
trial → ReceivesAction → held in october	0.36
trial → CapableOf → provide answer	0.36
trial → CapableOf → start in 2014	0.36
trial → ReceivesAction → set for august	0.36
trial → CapableOf → involve thousands of participants	0.36
trial → ReceivesAction → conducted in south korea	0.36
trial → ReceivesAction → divided into three phases	0.36
trial → HasProperty → more precious than gold	0.36
trial → HasProperty → acceptable	0.36
trial → ReceivesAction → conducted in spain	0.36
trial → ReceivesAction → added	0.36
trial → CapableOf → begin in federal court	0.36
trial → ReceivesAction → set for monday	0.36
trial → CapableOf → gather information	0.36
trial → ReceivesAction → held on saturday	0.36
trial → CapableOf → run until june	0.36
trial → ReceivesAction → held in federal court	0.36
trial → CapableOf → begin on jan.	0.36
trial → ReceivesAction → conducted in new zealand	0.36
trial → CapableOf → sit without jury	0.36
trial → HasProperty → legal	0.36
trial → ReceivesAction → funded by the nih	0.36
trial → CapableOf → continue to next stage	0.36
trial → CapableOf → last 14 days	0.36
trial → CapableOf → proceed to conclusion	0.36
investigation → HasSubevent → trial	0.36
trial → HasA → 80% power	0.36
trial → ReceivesAction → held in camera	0.36
trial → HasA → power	0.36
trial → ReceivesAction → proposed	0.36
trial → CapableOf → last four months	0.36
trial → ReceivesAction → watched	0.36
trial → CapableOf → begin on friday	0.36
trial → ReceivesAction → conducted in belgium	0.36
trial → CapableOf → end with guilty verdict	0.36
trial → ReceivesAction → sponsored by the university of warwick	0.36
trial → CapableOf → start on wednesday	0.36
trial → ReceivesAction → conducted in uganda	0.36
trial → ReceivesAction → prepared	0.36
trial → CapableOf → enrol only patients	0.36
trial → CapableOf → focus on safety	0.36
trial → ReceivesAction → registered with isrctn	0.36
trial → ReceivesAction → waived	0.36
trial → ReceivesAction → restricted to patient	0.36
trial → CapableOf → end in may	0.36
trial → AtLocation → recess	0.36
trial → ReceivesAction → written by franz kafka	0.36
trial → CapableOf → evaluate the relationship	0.36
trial → CapableOf → gather additional information	0.36
trial → ReceivesAction → allowed in said court	0.36
trial → HasProperty → unnecessary	0.36
trial → HasProperty → burdensome	0.35
trial → HasProperty → stressful	0.35
trial → HasProperty → significant	0.35
trial → HasProperty → illegal	0.35
new trial (subgroup of trial) → ReceivesAction → granted by appellate court	0.35
trial → ReceivesAction → sponsored by the national heart	0.35
trial → ReceivesAction → held in new york city	0.35
trial → CapableOf → continue for week	0.35
trial → CapableOf → draw to close	0.35
trial → HasProperty → speedy	0.35
trial → HasA → precedence	0.35
trial → AtLocation → such county	0.35
trial → ReceivesAction → funded by the wellcome trust	0.35
trial → CapableOf → come in question	0.35
trial → ReceivesAction → published to date	0.35
trial → ReceivesAction → conducted in mexico	0.35
trial → ReceivesAction → expedited	0.35
trial → ReceivesAction → published in 2005	0.35
trial → CapableOf → provide the basis	0.35
trial → ReceivesAction → sponsored by novartis	0.35
trial → ReceivesAction → protected	0.35
trial → CapableOf → generate datum	0.35
trial → CapableOf → begin in 2007	0.35
trial → IsA → event	0.35
trial → ReceivesAction → conducted in finland	0.35
trial → ReceivesAction → published in 2010	0.35
trial → ReceivesAction → passed	0.35
trial → CapableOf → involve wrongful death	0.35
case (aspect of lawyer) → HasPrerequisite → trial	0.35
trial → ReceivesAction → found unto glory	0.35
trial → ReceivesAction → conducted in parallel	0.34
trial → ReceivesAction → conducted in melbourne	0.34
trial → CapableOf → determine damage	0.34
trial → CapableOf → enrol 182 patients	0.34
trial → CapableOf → start in europe	0.34
trial → ReceivesAction → based on fact	0.34
trial → CapableOf → run for three months	0.34
trial → CapableOf → begin in 2010	0.34
trial → CapableOf → resume in january	0.34
trial → ReceivesAction → scored	0.34
trial → ReceivesAction → based on evidence	0.34
trial → ReceivesAction → sponsored by blood	0.34
trial → CapableOf → set the stage	0.34
trial → CapableOf → last several weeks	0.34
trial → CapableOf → use cross-over design	0.34
trial → CapableOf → provide sufficient data	0.34
trial → ReceivesAction → held at the old bailey	0.34
trial → ReceivesAction → published in 2011	0.34
trial → HasSubevent → guilty verdict	0.34
trial → ReceivesAction → conducted in kenya	0.34
trial → ReceivesAction → restarted	0.34
trial → CapableOf → last for approximately 18 months	0.34
trial → CapableOf → end on july	0.34
trial → CapableOf → involve two trials	0.34
trial → HasProperty → sure	0.34
trial → ReceivesAction → designed to assess effectiveness	0.34
trial → CapableOf → compare varenicline	0.34
trial → CapableOf → apply to decision	0.34
trial → CapableOf → compared ertapenem	0.34
trial → ReceivesAction → handled	0.34
trial → ReceivesAction → stopped for efficacy	0.34
trial → ReceivesAction → eliminated	0.34
matter → RelatedTo → trial	0.34
trial → CapableOf → last week	0.34
trial → HasProperty → cheaper	0.34
trial → ReceivesAction → omitted	0.34
trial → ReceivesAction → used by god	0.34
trial → CapableOf → begin in 2018	0.34
trial → ReceivesAction → sponsored by eli lilly	0.34
trial → ReceivesAction → funded by the charity	0.34
trial → ReceivesAction → conducted in sydney	0.34
trial → ReceivesAction → structured	0.34
trial → CapableOf → compared azithromycin	0.34
trial → ReceivesAction → likely to result	0.34
trial → ReceivesAction → set for next month	0.34
trial → CapableOf → focus on smoker	0.34
trial → HasProperty → unprecedented	0.34
trial → CapableOf → run until november	0.34
trial → CapableOf → start in 2012	0.34
trial → CapableOf → conclude on august	0.34
trial → ReceivesAction → conducted in brazil	0.34
trial → CapableOf → open on monday	0.34
trial → ReceivesAction → conducted in africa	0.34
trial → HasPrerequisite → large sample sizes	0.34
trial → CapableOf → last until june	0.34
trial → ReceivesAction → stayed	0.34
trial → HasA → several strengths	0.34
trial → HasA → one of two outcomes	0.34
trial → CapableOf → combine pembrolizumab	0.34
trial → CapableOf → test the feasibility	0.34
trial → ReceivesAction → broadcast on television	0.34
trial → CapableOf → measure effectiveness	0.34
trial → CapableOf → report clinical outcomes	0.34
trial → ReceivesAction → bifurcated	0.34
trial → ReceivesAction → presided by judge	0.34
trial → CapableOf → begin in 2013	0.34
trial → HasProperty → full	0.34
trial → ReceivesAction → performed on larger groups	0.34
trial → CapableOf → involve 658 adults	0.34
trial → ReceivesAction → held at the start of the year	0.34
trial → HasProperty → inconclusive	0.34
trial → HasProperty → controversial	0.34
trial → HasProperty → frustrating	0.33
trial → ReceivesAction → never published	0.33
trial → HasProperty → interesting	0.33
trial → HasProperty → more precious	0.33
trial → ReceivesAction → sponsored by the national center	0.33
trial → CapableOf → last five days	0.33
trial → CapableOf → compare radiotherapy	0.33
trial → CapableOf → begin in the uk	0.33
trial → ReceivesAction → conducted by a team of individuals	0.33
trial → ReceivesAction → completed in january	0.33
trial → ReceivesAction → adapted	0.33
trial → ReceivesAction → published in march	0.33
trial → CapableOf → assess risk	0.33
trial → ReceivesAction → funded by the department	0.33
trial → CapableOf → involve 30 patients	0.33
trial → ReceivesAction → conducted in sweden	0.33
trial → CapableOf → last two months	0.33
trial → CapableOf → last until august	0.33
trial → CapableOf → vary in length	0.33
trial → CapableOf → take place in spain	0.33
trial → ReceivesAction → given with paclitaxel	0.33
trial → HasProperty → favourable	0.33
trial → ReceivesAction → completed in june	0.33
trial → ReceivesAction → conducted in english	0.33
trial → CapableOf → continue on thursday	0.33
trial → ReceivesAction → likely to begin	0.33
trial → CapableOf → last 10 weeks	0.33
trial → ReceivesAction → sponsored by the nci	0.33
trial → CapableOf → run for 12 months	0.33
trial → ReceivesAction → conducted in south america	0.33
trial → ReceivesAction → adjourned to another date	0.33
trial → ReceivesAction → conducted in thailand	0.33
trial → ReceivesAction → avoided	0.33
trial → AtLocation → progress	0.33
trial → HasProperty → painful	0.33
trial → CapableOf → enroll small numbers of people	0.33
trial → HasProperty → quick	0.33
trial → CapableOf → address the question	0.33
trial → ReceivesAction → criticized	0.33
trial → CapableOf → confirm efficacy	0.33
trial → CapableOf → come at time	0.32
trial → CapableOf → assess the impact of itns	0.32
trial → HasProperty → more likely	0.32
trial → CapableOf → provide further data	0.32
trial → CapableOf → evaluate cost-effectiveness	0.32
trial → ReceivesAction → divided into two groups	0.32
trial → CapableOf → take many forms	0.32
trial → CapableOf → run to april	0.32
trial → ReceivesAction → published in 2008	0.32
trial → ReceivesAction → funded by the national institute of diabetes	0.32
trial → HasA → two stages	0.32
trial → CapableOf → be a feasibility study	0.32
trial → HasProperty → long-lasting	0.32
trial → CapableOf → meet our selection criteria	0.32
trial → ReceivesAction → completed under nct02722408	0.32
trial → ReceivesAction → conducted in switzerland	0.32
trial → ReceivesAction → overseen by a steering committee	0.32
trial → ReceivesAction → run with school	0.32
trial → CapableOf → involve money-laundering charges	0.32
trial → HasProperty → upcoming	0.32
trial → ReceivesAction → adjourned for week	0.32
trial → CapableOf → commence within 365 days	0.32
trial → CapableOf → begin with central fixation	0.32
trial → ReceivesAction → dismissed	0.32
trial → ReceivesAction → approved by health canada	0.32
trial → ReceivesAction → conducted by a research team	0.32
trial → ReceivesAction → designed to evaluate immunogenicity	0.32
trial → ReceivesAction → administered	0.32
trial → CapableOf → draw attention	0.32
trial → ReceivesAction → conducted in costa rica	0.32
trial → CapableOf → assess the nature of tackles	0.32
trial → CapableOf → assess head injury events	0.32
trial → ReceivesAction → led by the world health organization	0.32
trial → CapableOf → test the effectiveness of interventions	0.32
trial → HasProperty → varied	0.32
trial → ReceivesAction → conducted in absentia	0.32
trial → CapableOf → begin with central fixation cross	0.32
trial → HasProperty → secret	0.32
trial → HasProperty → swift	0.32
trial → ReceivesAction → conducted at site	0.32
trial → CapableOf → achieve statistical significance	0.32
trial → ReceivesAction → scheduled for next year	0.32
trial → ReceivesAction → explored	0.32
trial → ReceivesAction → completed in february	0.32
trial → HasProperty → expeditious	0.32
trial → ReceivesAction → held in september	0.32
trial → ReceivesAction → known in each state	0.32
trial → ReceivesAction → demanded	0.32
trial → CapableOf → aim to assess safety	0.32
trial → ReceivesAction → designed to evaluate following end points	0.32
trial → ReceivesAction → funded by nonprofit or nonfederal organizations	0.32
trial → CapableOf → use innovative design	0.32
trial → CapableOf → test the technology	0.32
trial → ReceivesAction → adjourned until february	0.32
trial → CapableOf → begin in 2008	0.32
trial → CapableOf → report quality of life	0.32
trial → CapableOf → go on for long time	0.32
right (aspect of child) → HasA → trial	0.32
jury trial (subgroup of trial) → IsA → trial	0.32
phase trial (subgroup of trial) → CapableOf → use telemonitoring	0.32
trial → CapableOf → give hope	0.32
trial → ReceivesAction → discontinued	0.32
trial → ReceivesAction → postponed to september	0.32
trial → CapableOf → continue to recruit participant	0.32
trial → HasSubevent → change	0.32
trial → ReceivesAction → proceeded	0.32
trial → CapableOf → serve the ends of justice	0.32
trial → CapableOf → continue through rhododendron	0.32
trial → CapableOf → continue through hemlock	0.32
trial → CapableOf → end on friday	0.32
trial → CapableOf → begin in buenos aires	0.32
trial → ReceivesAction → approved by local ethics committee	0.32
trial → CapableOf → last a few hours	0.32
trial → CapableOf → remain in abeyance	0.32
trial → ReceivesAction → fought	0.32
trial → ReceivesAction → funded by two uk funding agencies	0.32
trial → ReceivesAction → published in abstract form	0.32
trial → HasProperty → the longest	0.32
trial → ReceivesAction → registered in the dutch trial register	0.32
trial → ReceivesAction → sponsored by other federal agencies	0.32
trial → CapableOf → compare different doses	0.32
trial → HasProperty → homogeneous	0.32
trial → ReceivesAction → held in the netherlands	0.32
trial → ReceivesAction → published in peer-reviewed journals	0.32
trial → ReceivesAction → staged	0.32
trial → ReceivesAction → had on complaint	0.32
trial → ReceivesAction → conducted at the university of california	0.32
trial → ReceivesAction → held at special court	0.32
trial → CapableOf → involve more people	0.32
trial → ReceivesAction → published in 1996	0.32
trial → ReceivesAction → joined with date	0.32
trial → CapableOf → begin in 2001	0.32
trial → HasA → three phases	0.32
trial → ReceivesAction → conducted in peru	0.32
trial → HasA → outcome	0.32
trial → ReceivesAction → published since 2002	0.32
trial → ReceivesAction → funded by melinda gates foundation	0.32
trial → CapableOf → bring closure	0.32
trial → ReceivesAction → held in closed session	0.32
trial → CapableOf → take statin	0.32
trial → AtLocation → four phases	0.32
trial → CapableOf → find procedure	0.32
trial → CapableOf → take place in coventry	0.32
trial → CapableOf → test the vaccine’s safety	0.32
trial → CapableOf → find clear differences	0.32
trial → CapableOf → remain open	0.32
trial → HasProperty → pivotal	0.32
trial → ReceivesAction → funded by niaid	0.32
trial → CapableOf → answer important questions	0.32
trial → HasA → different purpose	0.32
trial → CapableOf → move to second phase	0.32
trial → ReceivesAction → split into two parts	0.32
trial → ReceivesAction → held in scotland	0.32
trial → ReceivesAction → guaranteed	0.32
trial → ReceivesAction → established in cooperation	0.32
trial → ReceivesAction → confirmed	0.32
trial → CapableOf → take place in tanzania	0.32
trial → CapableOf → apply to ehc plans	0.32
trial → HasA → protocol	0.32
trial → CapableOf → assess anti-tumor activity	0.32
trial → CapableOf → involve 435 children	0.32
trial → CapableOf → start on thursday	0.32
trial → ReceivesAction → constructed	0.32
trial → ReceivesAction → completed on time	0.32
trial → CapableOf → start in hungary	0.32
trial → HasProperty → over	0.32
trial → ReceivesAction → shown in figure	0.32
trial → ReceivesAction → published in 2007	0.32
trial → ReceivesAction → set within 6 judicial workingdays	0.32
trial → HasSubevent → the judgment of conviction	0.32
trial → ReceivesAction → conducted in 1970	0.32
trial → ReceivesAction → designed to answer the question	0.32
trial → CapableOf → start in australia	0.32
trial → HasA → adequate allocation concealment	0.32
trial → ReceivesAction → due to last	0.32
trial → CapableOf → resume on june	0.32
trial → ReceivesAction → conducted at the university of texas	0.32
trial → ReceivesAction → appointed to be had before the governor	0.32
trial → ReceivesAction → designed in consultation	0.32
trial → CapableOf → open in april	0.32
trial → CapableOf → collect pharmacokinetic data	0.32
trial → ReceivesAction → conducted at 5 locations	0.32
controlled trial (subgroup of trial) → CapableOf → permit conclusion	0.32
trial → CapableOf → proceed	0.31
trial → HasProperty → unpredictable	0.31
trial → ReceivesAction → lost	0.31
trial → HasProperty → bad	0.31
trial → ReceivesAction → completed in november	0.31
trial → CapableOf → focus on efficacy	0.31
trial → CapableOf → open on june	0.31
trial → CapableOf → determine liability	0.31
trial → ReceivesAction → conducted in london	0.31
trial → CapableOf → begin in london	0.31
trial → CapableOf → last four to six weeks	0.31
trial → CapableOf → continue before mr justice tony hunt	0.31
trial → ReceivesAction → presented in total	0.31
trial → ReceivesAction → announced in january	0.31
trial → ReceivesAction → sponsored by academic institutions	0.31
trial → ReceivesAction → sponsored by institute	0.31
trial → HasProperty → thorough	0.31
trial → CapableOf → assess qol	0.31
trial → CapableOf → involve 14 patients	0.31
trial → ReceivesAction → intermixed	0.31
trial → CapableOf → begin in 2003	0.31
trial → ReceivesAction → conducted by the national cancer institute	0.31
trial → ReceivesAction → conducted in israel	0.31
trial → ReceivesAction → conducted in august	0.31
trial → AtLocation → two different places	0.31
trial → ReceivesAction → published in the nejm	0.31
trial → ReceivesAction → designed to evaluate the proportion of patients	0.31
trial → CapableOf → continue for day	0.31
trial → ReceivesAction → funded by the bill	0.31
trial → ReceivesAction → sponsored by roche	0.31
trial → CapableOf → involve personal injury	0.31
trial → CapableOf → involve uma bharti	0.31
trial → ReceivesAction → concluded in two years	0.31
trial → ReceivesAction → held in a lucknow court	0.31
trial → ReceivesAction → scheduled to begin may	0.31
trial → CapableOf → take place in milton keynes	0.31
trial → CapableOf → proceed with new members	0.31
trial → ReceivesAction → held in courtroom	0.31
trial → HasProperty → honest	0.31
trial → ReceivesAction → judged on speed	0.31
trial → CapableOf → begin before the end of the year	0.31
trial → CapableOf → estimate child's physical activity	0.31
trial → HasSubevent → the decision	0.31
trial → HasProperty → unavoidable	0.31
trial → ReceivesAction → ignored	0.31
trial → CapableOf → report adverse events	0.30
trial → ReceivesAction → compared	0.30
trial → ReceivesAction → found unto honour	0.30
trial → CapableOf → exclude people	0.30
trial → CapableOf → find difference	0.30
trial → HasProperty → valuable	0.30
trial → HasProperty → informative	0.30
trial → HasProperty → fun	0.29
trial → HasProperty → unjust	0.29
trial → CapableOf → decide the facts of the case	0.29
trial → HasProperty → big	0.29
trial → HasProperty → longer	0.29
trial → ReceivesAction → conducted to date	0.29
intolerance → HasSubevent → trial	0.29
trial → ReceivesAction → stopped for futility	0.29
trial → HasProperty → efficient	0.29
trial → CapableOf → play critical role	0.29
phase trial (subgroup of trial) → HasProperty → positive	0.29
trial → HasProperty → more effective	0.29
free trial (subgroup of trial) → CapableOf → begin on the day	0.28
trial → ReceivesAction → difficult to conduct	0.28
trial → CapableOf → build character	0.28
right (aspect of petitioner) → HasA → trial	0.28
trial → CapableOf → be a travesty of justice	0.28
trial → HasProperty → more complicated	0.28
trial → HasProperty → overwhelming	0.27
trial → CapableOf → show significant benefit	0.27
trial → HasProperty → unconstitutional	0.27
trial → CapableOf → open the door	0.27
trial → CapableOf → produce result	0.27
trial → CapableOf → report improvement	0.27
trial → HasSubevent → glory	0.27
trial → CapableOf → save money	0.27
trial → ReceivesAction → delayed by procedural matters	0.27
trial → HasProperty → fine	0.27
trial → HasSubevent → praise	0.26
trial → HasProperty → invalid	0.26
trial → CapableOf → provide strong evidence	0.26
trial → ReceivesAction → interrupted	0.26
trial → HasProperty → exhausting	0.26
trial → CapableOf → take place in australia	0.26
trial → ReceivesAction → conducted in way	0.26
trial → HasProperty → easier	0.26
trial → CapableOf → drag on for year	0.26
trial → CapableOf → be a turning point	0.26
trial → CapableOf → get used to get a number of messages	0.26
trial → ReceivesAction → published in chinese journals	0.26
trial → ReceivesAction → politicised	0.25
trial → HasProperty → popular	0.25
trial → HasA → positive outcome	0.25
trial → CapableOf → drag on for month	0.25
trial → HasProperty → slow	0.25
trial → CapableOf → sentenced to death	0.25
trial → CapableOf → explore the potential	0.25
controlled trial (subgroup of trial) → CapableOf → report on clinical outcomes	0.25
controlled trial (subgroup of trial) → ReceivesAction → planned	0.25
criminal trial (subgroup of trial) → ReceivesAction → conducted within ethical standards of the profession	0.25
fair trial (subgroup of trial) → ReceivesAction → provided in article 47 of the charter	0.25
jury trial (subgroup of trial) → ReceivesAction → granted	0.25
jury trial (subgroup of trial) → ReceivesAction → available in the united states	0.25
jury trial (subgroup of trial) → ReceivesAction → requested in writing	0.25
new trial (subgroup of trial) → CapableOf → commence within 365 days	0.25
new trial (subgroup of trial) → CapableOf → become available	0.25
phase trial (subgroup of trial) → CapableOf → evaluate cndo-109-activated allogeneic natural killer	0.25
phase trial (subgroup of trial) → ReceivesAction → designed to speed up the development	0.25
phase trial (subgroup of trial) → ReceivesAction → warranted	0.25
phase trial (subgroup of trial) → ReceivesAction → conducted in india	0.25